S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
OSRH$0.156-2.50%
OSR Health, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: BiotechnologyCountry: USExchange: OTC
Mkt Cap:$5.48M
Float & O/S:
Inst Own:
DilutionScan read 29 of OSR Health, Inc.'s SEC filings and found 3 warrant series, 4 convertibles, 1 equity line, 1 S-1 registration and 4 completed offerings on file for OSRH. The latest dilution event on file is an offering on Apr 7, 2026. Analysis updated Oct 16, 2026.
Signal8 Summary
OSRH
Negative cash runway
Snapshot
OSR Holdings is a biotech micro-cap with a shrinking business and negative cash runway. FY 2025 revenue was $2.9M (down 17.7% YoY), and the company lost $18.0M, with a gross margin of 20.4%. Operating cash flow was $-4.3M, and free cash flow was $-4.5M.
What's Happening Right Now
- : CEO Kuk Hyoun Hwang committed to no reverse stock split, providing transparency regarding the company's strategy.
- : OSR Holdings signed an $815 million global license agreement for VXM01 with BCM Europe, reinforcing alignment with public shareholders.
- : OSR Holdings eliminated $2.02 million of warrant overhang by consolidating them into a convertible promissory note.
- : OSR Holdings received a 180-day Nasdaq extension to regain compliance with the minimum $1.00 bid price requirement.
Raise routes on file: effective S-1 + active equity line · latest dilution event 210 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Apr 7, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Equity line
Issued 2025
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your OSRH trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
